Pubertal delay as an aid in diagnosis and
treatment of a transsexual adolescent.
Cohen-Kettenis PT, van Goozen SH.
Department of Child and Adolescent Psychiatry
of the
Utrecht University Hospital, The Netherlands.
Abstract [Full Text] [PDF]
Abstract
Early cross-sex hormonal interventions (that
is, between 16 and 18) as a treatment for young transsexuals are often
considered to be risky. However, the delay of such treatment until after the
development of secondary sex characteristics has obvious drawbacks for
transsexual individuals.
This paper reports a postoperative
follow-up case-study of a female-to-male transsexual who was treated with a
combination of an LHRH agonist (which delayed her secondary sex
characteristics development) and psychotherapy at age 13, and subsequently
underwent sex reassignment at 18.
Citation:
Eur Child Adolesc Psychiatry 1998 Dec;7(4):246-8
an article published on the Internet by PubMed <http://www.ncbi.nlm.nih.gov/>
